Abstract:Background: Arboviruses are RNA viruses and some have the potential to cause neuroinvasive disease and are a growing threat to global health. Objectives: Our objective is to identify and map all aspects of arbovirus neuroinvasive disease, clarify key concepts, and identify gaps within our knowledge with appropriate future directions related to the improvement of global health. Methods: Sources of Evidence: A scoping review of the literature was conducted using PubMed, Scopus, ScienceDirect, and Hinari. Eligibility Criteria: Original data including epidemiology, risk factors, neurological manifestations, neuro-diagnostics, management, and preventive measures related to neuroinvasive arbovirus infections was obtained. Sources of evidence not reporting on original data, non-English, and not in peer-reviewed journals were removed. Charting Methods: An initial pilot sample of 30 abstracts were reviewed by all authors and a Cohen's kappa of κ = 0.81 (near-perfect agreement) was obtained. Records were manually reviewed by two authors using the Rayyan QCRI software. Results: A total of 171 records were included. A wide array of neurological manifestations can occur most frequently, including parkinsonism, encephalitis/encephalopathy, meningitis, flaccid myelitis, and Guillain-Barré syndrome. Magnetic resonance imaging of the brain often reveals subcortical lesions, sometimes with diffusion restriction consistent with acute ischemia. Vertical transmission of arbovirus is most often secondary to the Zika virus. Neurological manifestations of congenital Zika syndrome, include microcephaly, failure to thrive, intellectual disability, and seizures. Cerebrospinal fluid analysis often shows lymphocytic pleocytosis, elevated albumin, and protein consistent with blood-brain barrier dysfunction. Conclusions: Arbovirus infection with neurological manifestations leads to increased morbidity and mortality. Risk factors for disease include living and traveling in an arbovirus endemic zone, age, pregnancy, and immunosuppressed status. The management of neuroinvasive arbovirus disease is largely supportive and focuses on specific neurological complications. There is a need for therapeutics and currently, management is based on disease prevention and limiting zoonosis.

Vector-borne threats: Sustainable approaches to their diagnosis and treatment

Integrated control strategies for dengue, Zika, and Chikungunya virus infections

Chikungunya: The Silent Threat in the Shadows

Neurological manifestations of Flaviviridae, Togaviridae, and Peribunyaviridae as vector-borne viruses

Progress Towards Research on Mosquito-Borne Arboviral Transmission and Infection.

Epidemiological trends of mosquito-borne viral diseases in Pakistan

Mosquito-Borne Viral Disease : A Threat to Global Health

Prevention and Control Strategies to Counter Dengue Virus Infection

A Review of Pathogens Transmitted by the Container-Inhabiting Mosquitoes, Aedes Albopictus, A Global Public Health Threat

Neuroinvasion of emerging and re-emerging arboviruses: A scoping review

Dengue virus: A global human threat: Review of literature

Aedes aegypti and Ae. albopictus microbiome/virome: new strategies for controlling arboviral transmission?

Global risk mapping for major diseases transmitted by Aedes aegypti and Aedes albopictus

Vector-Borne Diseases Potpourri

Current Efforts in the Development of Vaccines for the Prevention of Zika and Chikungunya Virus Infections

Chikungunya: An Emerging Public Health Concern

Global health concern on the rising dengue and chikungunya cases in the American regions: Countermeasures and preparedness

From mosquitoes to menace: Unveiling the dangers of West Nile virus in Pakistan

Arbovirus surveillance in mosquitoes: Historical methods, emerging technologies, and challenges ahead

Challenges in combating arboviral infections

Chikungunya Virus: An Emergent Arbovirus to the South American Continent and a Continuous Threat to the World